(Q44605542)

English

Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia

scientific article published on December 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia (English)

1 reference

Europe PubMed Central

4 December 2017

Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia (English)

1 reference

10.1038/SJ.LEU.2403139

https://api.crossref.org/works/10.1038/SJ.LEU.2403139

17 March 2024

0 references

1 reference

10.1038/SJ.LEU.2403139

https://api.crossref.org/works/10.1038/SJ.LEU.2403139

17 March 2024

author name string

Kolb JP

5

1 reference

Europe PubMed Central

4 December 2017

C. Billard

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523476

17 March 2024

C. Kern

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523476

17 March 2024

R. Tang

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523476

17 March 2024

F. Ajchenbaum-Cymbalista

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523476

17 March 2024

J-P Kolb

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14523476

17 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14523476

17 March 2024

publication date

1 December 2003

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

https://www.nature.com/articles/2403139.pdf

Portable Document Format

1 reference

10.1038/SJ.LEU.2403139

https://api.crossref.org/works/10.1038/SJ.LEU.2403139

17 March 2024

https://www.nature.com/articles/2403139

1 reference

10.1038/SJ.LEU.2403139

https://api.crossref.org/works/10.1038/SJ.LEU.2403139

17 March 2024

1 reference

Europe PubMed Central

4 December 2017

17

1 reference

Europe PubMed Central

4 December 2017

12

1 reference

Europe PubMed Central

4 December 2017

2435-2443

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403139

0 references

Characterization of rat TOM40, a central component of the preprotein translocase of the mitochondrial outer membrane

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Mechanisms of action of flavopiridol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

p27KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma-induced tyrosine phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Flavopiridol induces apoptosis in B-cell chronic lymphocytic leukaemia cells through a p38 and ERK MAP kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

S-Nitrosylation of mitochondrial caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Perspectives for cancer therapies with cdk2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Developmental therapeutics program at the NCI: molecular target and drug discovery process

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

21 January 2018

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

7 January 2021

based on heuristic

inferred from DOI database lookup

Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403139

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403139

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44605542&oldid=2126520028"